# Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)

> **NCT01601795** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 30 (actual)

## Conditions studied

- Myocardial Reperfusion Injury

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Isoflurane

## Key facts

- **NCT ID:** NCT01601795
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-01-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601795, "Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01601795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*